Orchard Therapeutics plc 4 SEC Filings

Filed On	Filing
24 Jan 2024	Form 4: Secor Alicia, Director Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Geraghty James A, Director Returned 44,391 shares to the issuer · Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Thomas Frank E, See Remarks Returned 92,081 shares to the issuer · Disposed of 2,240,460 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Rowland Charles A Jr, Director Returned 12,294 shares to the issuer · Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Beck Joanne T., Director Returned 9,294 shares to the issuer · Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Gaspar Bobby, Director Returned 366,158 shares to the issuer · Disposed of 4,184,280 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Dunoyer Marc, Director Returned 37,179 shares to the issuer · Disposed of 231,030 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Altschuler Steven, Director Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Jan 2024	Form 4: Curnutte John T, Director Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Altschuler Steven, Director Granted 105,000 Stock Option (Right to Buy)
16 Jun 2023	Form 4: Curnutte John T, Director Granted 105,000 Stock Option (Right to Buy)
16 Jun 2023	Form 4: Dunoyer Marc, Director Granted 105,000 Stock Option (Right to Buy)
16 Jun 2023	Form 4: Geraghty James A, Director Granted 105,000 Stock Option (Right to Buy)
16 Jun 2023	Form 4: Secor Alicia, Director Granted 105,000 Stock Option (Right to Buy)
16 Jun 2023	Form 4: Beck Joanne T., Director Granted 105,000 Stock Option (Right to Buy)
16 Jun 2023	Form 4: Rowland Charles A Jr, Director Granted 105,000 Stock Option (Right to Buy)
14 Mar 2023	Form 4: Thomas Frank E, See Remarks Received 20,000 shares by exercise or conversion ($9.18K)
03 Mar 2023	Form 4: Thomas Frank E, See Remarks Granted 585,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Gaspar Bobby, Director Granted 1,145,000 Stock Option (Right to Buy)
13 Feb 2023	Form 4: Thomas Frank E, See Remarks Received 20,000 shares by exercise or conversion ($9.18K)

Comments